Paris Makrantonakis

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)

John Souglakos, N. Ziras, Stylianos Kakolyris et al. · British Journal of Cancer · 2012 · 64 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project

John Souglakos, Ioannis Boukovinas, Stylianos Kakolyris et al. · Annals of Oncology · 2019 · 47 citations · Full text

Medicine, Oncology, Chemotherapy +12

Radiation Therapy and Concurrent Cisplatin Administration in Locally Advanced Head and Neck Cancer a Hellenic Co-Operative Oncology Group Study

George Fountzilas, Dimosthenis Skarlos, P. Kosmidis et al. · Acta Oncologica · 1994 · 32 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: A hellenic co-operative oncology group study

George Fountzilas, P. Kosmidis, V. Avramidis et al. · Medical and Pediatric Oncology · 1997 · 21 citations · Full text

Medicine, Oncology, Chemotherapy +12

Platinum-Based Chemotherapy Followed by Radiation Therapy of Locally Advanced Nasopharyngeal Cancer a Retrospective Analysis of 39 Cases

George Fountzilas, J. Daniilidis, P. Kosmidis et al. · Acta Oncologica · 1991 · 18 citations · Full text

Medicine, Oncology, Radiation Oncology +14